fbpx PixelServer

BC Cancer - Victoria

BC Cancer – Victoria is one of six regional cancer centres.

For more information, contact:

William Litchfield,
Executive Director

Your donations will be matched till May 31, 2024. Double your impact today.

BC Cancer – Victoria
2410 Lee Avenue
Victoria, BC V8R 6V5

Patients have access to:

  • world-class comprehensive cancer care and treatment close to home
  • vital supportive care services ranging from genetic or nutrition counselling to spiritual guidance

Integrated Care and Research Pavilion

BC Cancer – Victoria is expanding its campus, a 12,000 square foot building just 250 metres from the existing facilities. The purchase and renovation of the building will be fully donor-funded – a first in BC Cancer Foundation history.

The new building will create a standalone space for the centre’s Supportive Care services – programs that help patients manage the adverse physical and psychological side effects of cancer.

From April 1 to May 31, 2024, your donations to BC Cancer – Victoria will be matched. We invite you to double your impact. The Integrated Care and Research Pavilion will:

  • Enhance and expand the centre’s Supportive Care programs to meet the needs of patients and families
  • Create a healing environment for cancer patients and families while accessing Supportive Care services
  • Establish BC Cancer – Victoria as model for holistic cancer care, leading to improved outcomes and quality of life for people across the Island.

World-Class Deeley Research Centre

Located in Victoria, the Deeley Research Centre (DRC) is one of the first sites in the world to pioneer an immunotherapy research program that uses genomic approaches to generate more precise and potent immune responses against cancer.

Immunotherapy Clinical Trials

Deeley Research Centre Director Dr. Brad Nelson and his team are joining forces with experts at BC Cancer’s Genome Sciences Centre in Vancouver to deliver truly personalized immunotherapy to patients in B.C.

Adoptive T Cell Therapy (ACT) is one of the most promising forms of immunotherapy. ACT clinical trials have the potential to save the lives of British Columbians facing all types of cancer.